Kineta to Present at the Life Sciences Investor Forum December 14th
SEATTLE, Dec. 12, 2023 -- Kineta, Inc. , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced...